Cargando…

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?

Several large genome wide association studies have identified a locus in close proximity to the gene encoding the enzyme aminocarboxymuconate-semialdehyde-decarboxylase (ACMSD) to be associated with the risk for Parkinson’s disease (PD), tentatively suggesting that this enzyme might influence PD pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thirtamara-Rajamani, Keerthi, Li, Peipei, Escobar Galvis, Martha L., Labrie, Viviane, Brundin, Patrik, Brundin, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676848/ https://www.ncbi.nlm.nih.gov/pubmed/29103054 http://dx.doi.org/10.3233/JPD-171240

Ejemplares similares

Role of Inflammation in Suicide: From Mechanisms to Treatment
por: Brundin, Lena, et al.
Publicado: (2017)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
por: Li, Peipei, et al.
Publicado: (2021)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
por: George, Sonia, et al.
Publicado: (2019)

Low plasma serotonin linked to higher nigral iron in Parkinson’s disease
por: Jellen, Leslie C., et al.
Publicado: (2021)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
por: Xie, Aoji, et al.
Publicado: (2022)

Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson's Disease in Taiwan
por: Chang, Kuo-Hsuan, et al.
Publicado: (2019)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson’s disease etiology
por: Coetzee, Simon G., et al.
Publicado: (2016)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils
por: George, Sonia, et al.
Publicado: (2021)

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls
por: Bacelis, Jonas, et al.
Publicado: (2021)

Methylated Cytochrome P450 and the Solute Carrier Family of Genes Correlate With Perturbations in Bile Acid Metabolism in Parkinson’s Disease
por: Vishweswaraiah, Sangeetha, et al.
Publicado: (2022)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
por: Burbulla, Lena F., et al.
Publicado: (2021)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
por: Dunning, Christopher J.R., et al.
Publicado: (2013)

Oxytocin as a Modulator of Synaptic Plasticity: Implications for Neurodevelopmental Disorders
por: Rajamani, Keerthi Thirtamara, et al.
Publicado: (2018)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
por: Kulkarni, Aishwarya S, et al.
Publicado: (2022)

Introduction
por: Patrik, Brundin
Publicado: (2017)

Epigenetic Biomarkers for Parkinson’s Disease: From Diagnostics to Therapeutics
por: Jakubowski, Jennifer L., et al.
Publicado: (2017)

Genetic influences on nicotinic α5 receptor (CHRNA5) CpG methylation and mRNA expression in brain and adipose tissue
por: Ramsay, Jessica E., et al.
Publicado: (2015)

Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
por: Barker, Roger A., et al.
Publicado: (2016)

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis
por: Widner, Håkan, et al.
Publicado: (1988)

Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson’s Disease?
por: von Linstow, Christian U., et al.
Publicado: (2020)

Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
por: Lindqvist, Daniel, et al.
Publicado: (2012)

Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
por: Lema Tomé, Carla M., et al.
Publicado: (2012)

Parkinson Matters
por: Darweesh, Sirwan K.L., et al.
Publicado: (2018)

Rasagiline Ameliorates Olfactory Deficits in an Alpha-Synuclein Mouse Model of Parkinson's Disease
por: Petit, Géraldine H., et al.
Publicado: (2013)

The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's disease
por: Henderson, Michael X., et al.
Publicado: (2022)

Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration
por: Quansah, Emmanuel, et al.
Publicado: (2018)

Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancy
por: Sha, Qiong, et al.
Publicado: (2022)

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
por: Rey, Nolwen L., et al.
Publicado: (2016)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines
por: Ventorp, Filip, et al.
Publicado: (2017)

The Appendix in Parkinson’s Disease: From Vestigial Remnant to Vital Organ?
por: Killinger, Bryan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_3195fg8ctoueqg7htk83cv3pad